ASTCT and ISCT consensus recommendations on ex vivo gene therapy for sickle cell disease, covering eligibility, comparison with allogeneic HCT, mobilisation and apheresis, myeloablative conditioning, fertility preservation, psychosocial care and lifelong surveillance.
Guideline
Sharma et al. Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy